Accelerating Biotech Breakthroughs with Cloud HPC Solution on Cloudam for a Better Future of Human Health.
Technological innovations over the past decade have significantly reduced the cost of human genome sequencing, enabling researchers to conduct more in-depth studies of various diseases at a lower cost. Generally, these studies include sequencing large numbers of samples to find the causes of genetic disorders and diseases.
Image Source: NIH
The rapid evolution of genome sequencing technologies, from MERFISH (Multiplexed Error Robust Fluorescence In Situ Hybridization) to Slide-seq, and then to the spatial transcriptomics Stereo-seq, brings an evergrowing spatial resolution and coverage of the transcriptome. Among them, Stereo-seq, a spatial transcriptomics technology independently developed by BGI in early 2021, has achieved "nano-scale resolution" and "centimeter-scale panoramic field of view" at the same time. These advancements also bring challenges to HPC systems.